Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
128.44
+2.53 (2.01%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 145.67, with a low estimate of 135 and a high estimate of 160. The average target predicts an increase of 13.41% from the current stock price of 128.44.
Analyst Consensus: Buy
* Price targets were last updated on Mar 20, 2024.
Analyst Ratings
The average analyst rating for DGX stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 10 | 10 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Reiterates $145 | Hold | Reiterates | $145 | +12.89% | Mar 20, 2024 |
| Leerink Partners | Leerink Partners | Hold Initiates $135 | Hold | Initiates | $135 | +5.11% | Feb 26, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $140 → $155 | Hold → Strong Buy | Upgrades | $140 → $155 | +20.68% | Feb 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $150 → $145 | Hold | Maintains | $150 → $145 | +12.89% | Feb 2, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $145 → $150 | Hold | Maintains | $145 → $150 | +16.79% | Dec 20, 2023 |
Financial Forecast
Revenue This Year
9.50B
from 9.25B
Increased by 2.63%
Revenue Next Year
9.83B
from 9.50B
Increased by 3.52%
EPS This Year
8.84
from 7.49
Increased by 17.98%
EPS Next Year
9.50
from 8.84
Increased by 7.49%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 9.9B | 10.4B | 10.8B | 10.3B |
| Avg | 9.5B | 9.8B | 10.2B | 9.9B |
| Low | 9.2B | 9.4B | 9.7B | 9.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 6.9% | 9.4% | 9.6% | 0.8% |
| Avg | 2.6% | 3.5% | 3.6% | -3.0% |
| Low | -0.8% | -0.9% | -1.5% | -5.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 9.24 | 10.06 | 11.21 | 11.96 |
| Avg | 8.84 | 9.50 | 10.26 | 11.50 |
| Low | 8.52 | 8.95 | 9.34 | 11.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 23.4% | 13.8% | 18.1% | 16.5% |
| Avg | 18.0% | 7.5% | 8.1% | 12.1% |
| Low | 13.8% | 1.3% | -1.7% | 8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.